Antibody-sting agonist conjugates and their use in immunotherapy
US12311030B2 · kind B2 · utility
0Cited by
7References
17Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 16, 2021 |
| Grant date | May 27, 2025 |
| Priority date | — |
| Expiry date | Jun 24, 2043 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to, among other things, antibody-drug conjugates comprising a STING agonist cyclic di-nucleotide conjugated to an antibody, preparation methods therefor, and uses therefor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.